InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Lanza Frank J. Director active across 1 company, notably Harpoon Therapeutics, Inc.. In total, 3 filings have been recorded. History available since 26 November 2023. The latest transaction was disclosed on 7 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations